Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
British Journal of Cancer
|
October 4, 2007
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules
K M Li, L P Rivory, S J Clarke
The American Journal of Physiology
|
April 1, 1993
Hepatic intracellular pH during the prereplicative period following partial hepatectomy
D G Le Couteur, L P Rivory, S M Pond
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 1, 1997
The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms
M C Haaz, L P Rivory, C Riché, et al.
Journal of Gastroenterology and Hepatology
|
July 1, 1994
Glucose transport and hypoxia-reoxygenation injury in the perfused rat liver
D G Le Couteur, L P Rivory, S M Pond
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 11, 1998
Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes
M C Haaz, C Riché, L P Rivory, et al.
Transplantation
|
September 15, 1994
The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver
D G Le Couteur, L P Rivory, S M Pond
Journal of Chromatography. B, Biomedical Sciences and Applications
|
January 5, 2002
Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chromatography
L P Rivory, S J Clarke, M Boyer, et al.
Biochemical Pharmacology
|
October 11, 1996
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase
L P Rivory, M R Bowles, J Robert, et al.
Journal of Toxicology. Clinical Toxicology
|
January 1, 1993
Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog
S M Pond, L P Rivory, E C Hampson, et al.
Cancer Research
|
December 15, 1994
Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patients
L P Rivory, E Chatelut, P Canal, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
British Journal of Cancer
|
October 4, 2007
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules
K M Li, L P Rivory, S J Clarke
The American Journal of Physiology
|
April 1, 1993
Hepatic intracellular pH during the prereplicative period following partial hepatectomy
D G Le Couteur, L P Rivory, S M Pond
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 1, 1997
The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms
M C Haaz, L P Rivory, C Riché, et al.
Journal of Gastroenterology and Hepatology
|
July 1, 1994
Glucose transport and hypoxia-reoxygenation injury in the perfused rat liver
D G Le Couteur, L P Rivory, S M Pond
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 11, 1998
Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes
M C Haaz, C Riché, L P Rivory, et al.
Transplantation
|
September 15, 1994
The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver
D G Le Couteur, L P Rivory, S M Pond
Journal of Chromatography. B, Biomedical Sciences and Applications
|
January 5, 2002
Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chromatography
L P Rivory, S J Clarke, M Boyer, et al.
Biochemical Pharmacology
|
October 11, 1996
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase
L P Rivory, M R Bowles, J Robert, et al.
Journal of Toxicology. Clinical Toxicology
|
January 1, 1993
Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog
S M Pond, L P Rivory, E C Hampson, et al.
Cancer Research
|
December 15, 1994
Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patients
L P Rivory, E Chatelut, P Canal, et al.
Page
of 5